Key facts
- This page summarizes Steve M. Sabus's Form 3 filing for Syndax Pharmaceuticals Inc (SNDX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Dec 2022, 15:37.
Steve M. Sabus - 05 Dec 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- SNDX
- Reported as of
- 05 Dec 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Dec 2022, 15:37:12 UTC
- Prior SEC filing
- 17 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael A. Metzger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Steve M. Sabus filed Form 3 for Syndax Pharmaceuticals Inc (SNDX) on 05 Dec 2022.
Change
- Previous filing in this sequence was filed on 17 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.